BrightSpring stock climbs after Q1 beat and higher 2026 guidance raise outlook
BTSG•BrightSpring Health Services (BTSG) is rising after reporting Q1 2026 results that beat expectations and raising full-year 2026 revenue and adjusted EBITDA guidance. The company also highlighted stronger profitability and lower leverage exiting the quarter.
1) What’s moving the stock today
BrightSpring Health Services shares are moving higher as investors digest the company’s first-quarter 2026 earnings update and a raised full-year outlook. The company reported Q1 net revenue of $3.614 billion (+25.6% year over year), net income of $74 million (up from $9 million a year ago), and adjusted EBITDA of $190 million (+44.8% year over year), alongside increases to full-year 2026 revenue and adjusted EBITDA guidance.
2) The key numbers investors are reacting to
Beyond the headline revenue growth, the quarter showed sharper profit expansion: gross profit rose to $482 million (+42.5% year over year). Management also pointed to improving balance-sheet metrics, with leverage at 2.27x as of March 31, 2026, down from pro forma leverage of 2.60x at December 31, 2025 (figures exclude the Community Living divestiture impact).
3) Why guidance matters for the next leg
The guidance increase is the catalyst because it reframes expectations for 2026 performance after a strong start to the year. A higher full-year outlook can force estimate revisions, recalibrate valuation models tied to EBITDA, and increase confidence that the company’s post-divestiture operating profile can generate faster earnings growth than previously priced in.
